232 related articles for article (PubMed ID: 27866326)
21. AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid.
Meade AJ; Meloni BP; Mastaglia FL; Watt PM; Knuckey NW
Brain Res; 2010 Nov; 1360():8-16. PubMed ID: 20833150
[TBL] [Abstract][Full Text] [Related]
22. Increased vulnerability of hippocampal neurons with age in culture: temporal association with increases in NMDA receptor current, NR2A subunit expression and recruitment of L-type calcium channels.
Brewer LD; Thibault O; Staton J; Thibault V; Rogers JT; Garcia-Ramos G; Kraner S; Landfield PW; Porter NM
Brain Res; 2007 Jun; 1151():20-31. PubMed ID: 17433272
[TBL] [Abstract][Full Text] [Related]
23. AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures.
Meade AJ; Meloni BP; Cross J; Bakker AJ; Fear MW; Mastaglia FL; Watt PM; Knuckey NW
J Neurochem; 2010 Jan; 112(1):258-70. PubMed ID: 19878434
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity.
Haughey NJ; Nath A; Mattson MP; Slevin JT; Geiger JD
J Neurochem; 2001 Aug; 78(3):457-67. PubMed ID: 11483648
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of vitexin by inhibition of NMDA receptors in primary cultures of mouse cerebral cortical neurons.
Yang L; Yang ZM; Zhang N; Tian Z; Liu SB; Zhao MG
Mol Cell Biochem; 2014 Jan; 386(1-2):251-8. PubMed ID: 24141792
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.
MacDougall G; Anderton RS; Mastaglia FL; Knuckey NW; Meloni BP
Mol Brain; 2019 Jul; 12(1):66. PubMed ID: 31315638
[TBL] [Abstract][Full Text] [Related]
27. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
[TBL] [Abstract][Full Text] [Related]
28. NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury.
Cook DR; Gleichman AJ; Cross SA; Doshi S; Ho W; Jordan-Sciutto KL; Lynch DR; Kolson DL
J Neurochem; 2011 Sep; 118(6):1113-23. PubMed ID: 21749375
[TBL] [Abstract][Full Text] [Related]
29. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
[TBL] [Abstract][Full Text] [Related]
30. Calpain regulation of AMPA receptor channels in cortical pyramidal neurons.
Yuen EY; Gu Z; Yan Z
J Physiol; 2007 Apr; 580(Pt 1):241-54. PubMed ID: 17234699
[TBL] [Abstract][Full Text] [Related]
31. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection.
Ponce J; de la Ossa NP; Hurtado O; Millan M; Arenillas JF; Dávalos A; Gasull T
Stroke; 2008 Apr; 39(4):1269-75. PubMed ID: 18323503
[TBL] [Abstract][Full Text] [Related]
32. Thiol oxidation and altered NR2B/NMDA receptor functions in in vitro and in vivo pilocarpine models: implications for epileptogenesis.
Di Maio R; Mastroberardino PG; Hu X; Montero LM; Greenamyre JT
Neurobiol Dis; 2013 Jan; 49():87-98. PubMed ID: 22824136
[TBL] [Abstract][Full Text] [Related]
33. Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.
Brittain JM; Pan R; You H; Brustovetsky T; Brustovetsky N; Zamponi GW; Lee WH; Khanna R
Channels (Austin); 2012; 6(1):52-9. PubMed ID: 22373559
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 reduces NMDAR-mediated cytosolic Ca²⁺ overload and neuronal death via JAK/CaN signaling.
Ma SH; Zhuang QX; Shen WX; Peng YP; Qiu YH
Cell Calcium; 2015 Sep; 58(3):286-95. PubMed ID: 26104917
[TBL] [Abstract][Full Text] [Related]
35. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain.
Ali C; Nicole O; Docagne F; Lesne S; MacKenzie ET; Nouvelot A; Buisson A; Vivien D
J Cereb Blood Flow Metab; 2000 Jun; 20(6):956-66. PubMed ID: 10894179
[TBL] [Abstract][Full Text] [Related]
36. Reversible inhibition of intracellular calcium influx through NMDA receptors by imidazoline I(2) receptor antagonists.
Jiang SX; Zheng RY; Zeng JQ; Li XL; Han Z; Hou ST
Eur J Pharmacol; 2010 Mar; 629(1-3):12-9. PubMed ID: 19958763
[TBL] [Abstract][Full Text] [Related]
37. Role of the NR2A/2B subunits of the N-methyl-D-aspartate receptor in glutamate-induced glutamic acid decarboxylase alteration in cortical GABAergic neurons in vitro.
Monnerie H; Hsu FC; Coulter DA; Le Roux PD
Neuroscience; 2010 Dec; 171(4):1075-90. PubMed ID: 20923697
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
39. Bidentatide, a Novel Plant Peptide Derived from
Ding F; Bai Y; Cheng Q; Yu S; Cheng M; Wu Y; Zhang X; Liang X; Gu X
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360755
[TBL] [Abstract][Full Text] [Related]
40. Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly.
Gu B; Nakamichi N; Zhang WS; Nakamura Y; Kambe Y; Fukumori R; Takuma K; Yamada K; Takarada T; Taniura H; Yoneda Y
J Neurosci Res; 2009 Jul; 87(9):2145-56. PubMed ID: 19224577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
